AC-73 and Syrosingopine Inhibit SARS-CoV-2 Entry into Megakaryocytes by Targeting CD147 and MCT4

Isabella Spinello(Istituto Superiore di Sanità), Catherine Labbaye(Istituto Superiore di Sanità)

Viruses

January 4, 2024

10.3390/v16010082

Cited by 2

Related Papers

A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis

|Nature Cell Biology|2008|226

Targeting Lactate Metabolism by Inhibiting MCT1 or MCT4 Impairs Leukemic Cell Proliferation, Induces Two Different Related Death-Pathways and Increases Chemotherapeutic Sensitivity of Acute Myeloid Leukemia Cells

|Frontiers in Oncology|2021|52